Thériaque du suédois
Food supplement declared in France, decision dated 25 August 2025
Thériaque du suédois (ELIXALP) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).
- Brand
- ELIXALP
- Food business operator placing the product on the market
- SAS ELIXALP
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Flacon
- Daily dose
- 2ml
- Directions for use
- 15 gouttes 2X par jour dans un verre d'eau.
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Maladie rénale, Problèmes cardiaques, Problèmes de foie, Sous antidépresseurs, Sous traitement médicamenteux
Declaration 339247, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
Carlina spp. (zie ook lijst 3/voir aussi liste 3): dangerous plant prohibited in food in Belgium (list 1). The entire genus Carlina is listed. List 3 also covers Carlina acaulis L., parts: racine. L'analyse doit démontrer que la préparation ne contient aucune quantité détectable en oxyde de carline. L’huile essentielle isolée de cette plante n’est pas autorisée dans les compléments alimentaires. List 3 also covers Carlina acaulis subsp. caulescens (Lam.) Schübl. & G.Martens, parts: racine. L'analyse doit démontrer que la préparation ne contient aucune quantité détectable en oxyde de carline. L’huile essentielle isolée de cette plante n’est pas autorisée dans les compléments alimentaires. Check the plant part used, the preparation, the conditions and the product notification.
Source: Belgium, Royal Decree of 31 August 2021, plant lists (annex replaced on 30 January 2024), arrêté royal du 31 août 2021, annexe remplacée le 30 janvier 2024, liste 1, page PDF 67 ; liste 3, pages PDF 130, 130.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Matricaria chamomilla L. | Capitule | Extrait fluide hydroalcoolique | 0.32 ml |
| Angelica archangelica L. | Fruit | Extrait fluide hydroalcoolique | 0.28 ml |
| Carlina acaulis L. | Racine | Extrait fluide hydroalcoolique | 0.28 ml |
| Gentiana lutea L. | Racine | Extrait fluide hydroalcoolique | 0.24 ml |
| Rosmarinus officinalis L. | Feuille | Extrait fluide hydroalcoolique | 0.2 ml |
| Fraxinus excelsior L. | Feuille | Extrait fluide hydroalcoolique | 0.16 ml |
| Commiphora myrrha (Nees) Engl. | Gomme résine | Extrait fluide hydroalcoolique | 0.1 ml |
| Curcuma zedoaria (Christm.) Roscoe | Rhizome | Extrait fluide hydroalcoolique | 0.1 ml |
| Althaea officinalis L. | Racine | Extrait fluide hydroalcoolique | 0.093 ml |
| Althaea officinalis L. | Fleur | Extrait fluide hydroalcoolique | 0.093 ml |
| Althaea officinalis L. | Feuille | Extrait fluide hydroalcoolique | 0.093 ml |
| Crocus sativus L. | Stigmates | Extrait fluide hydroalcoolique | 0.04 ml |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Réservé à l’adulte. Déconseillé sous antidépresseur, en cas d'allergie aux Asteraceaes, de problème biliaires, cardiaque ou rénale œdémateuses, aux femmes enceintes et allaitantes. En cas de traitements, voir un médecin. Tenir hors de portée des enfants.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Matricaria chamomilla L.
Read the warning, when it applies and the studies cited
GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Oral
Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000; WHO 1999; Bradley 1992).
Cautions and warnings
When using this product exercise caution if you drive or use machinery as you may experience drowsiness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 19 December 2025
German Chamomile - Matricaria Chamomilla Topical
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 31 January 2025
GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Buccal
Route of administration: Buccal (ESCOP 2003; Blumenthal et al. 2000; Bradley 1992)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Angelica archangelica L.
Read the warning, when it applies and the studies cited
ANGELICA - ANGELICA ARCHANGELICA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Brinker 2010; Barnes et al. 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a peptic ulcer (Brinker 2010; Barnes et al. 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid prolonged exposure to sunlight, ultraviolet light (UV) or UV therapy (Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant (Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Gentiana lutea L.
Read the warning, when it applies and the studies cited
Gentian - Gentiana Lutea
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Contraindications
Do not use if you are pregnant (Hoffmann 2003; Morimoto et al.1983).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have stomach or duodenal acute inflammation or ulcer (Brinker 2010; ESCOP 2003; Bradley 1992).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
When using this product you may experience headaches (ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Rosmarinus officinalis L.
Read the warning, when it applies and the studies cited
ROSEMARY – ROSMARINUS OFFICINALIS Oral
Route of administration: Oral (ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 29 May 2026
ROSEMARY - ROSMARINUS OFFICINALIS Topical
Route of administration: Topical (ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Althaea officinalis L.
Read the warning, when it applies and the studies cited
Marshmallow - ALTHAEA OFFICINALIS - Root
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Health Canada monograph dated 19 December 2025
MARSHMALLOW - ALTHAEA OFFICINALIS - LEAF
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : ELIXALP
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.